Thursday, October 9, 2025 - Agenda

Learning Objectives:

• Differentiate breast cancer stages, subtypes, and key biomarkers.
• Outline the diagnostic workup and management of breast cancer treatment-related adverse effects.
• Implement evidence-based approaches to managing breast cancer complications.

Peter Lamie, DO, Onco-hospitalist, University of Texas - MD Anderson Cancer Center

Jason R. Beckrow, DO, FACOI, FAAHPM, HMDC (he/him/his), Assistant Professor, Michigan State University

More details coming soon

Massoud Mahmoudi, DO, FACOI

Robert W. Hostoffer, Jr., DO, FACOI (he/him/his), Associate Professor, Case Western Reserve University

More details coming soon

Learning Objectives:

• At the end of this lecture the audience will be able to understand the mechanism of anaphylaxis.
• At the end of this lecture the audience will understand the clinical presentations of anaphylaxis.
• At the end of this lecture the audience will be able to effectively use epinephrine in the treatment of anaphylaxis.

Robert W. Hostoffer, Jr., DO, FACOI (he/him/his), Associate Professor, Case Western Reserve University

Learning Objectives:

• Understand potential causes of colorectal cancer in patients less than 50 years of age.
• Understand screening guidelines and types of screening available for colorectal cancer.
• Understand signs and symptoms of colorectal cancer and how to address this in a younger population.

Navin Anthony, DO (he/him/his), Hematology/Oncology, UNC Pardee Hospital

Jason R. Beckrow, DO, FACOI, FAAHPM, HMDC (he/him/his), Assistant Professor, Michigan State University

More details coming soon

Daniel Isaac, DO

Jason R. Beckrow, DO, FACOI, FAAHPM, HMDC (he/him/his), Assistant Professor, Michigan State University

Learning Objectives:

• To introduce the audience to the spectrum of drug reactions.
• To introduce the audience to the determination of drug allergies.
• To introduce the audience to options when caring for patients with drug allergies.

Robert W. Hostoffer, Jr., DO, FACOI (he/him/his), Associate Professor, Case Western Reserve University

Learning Objectives:

• Understand cardiac anatomy and electrophysiologic basis of atrial fibrillation.
• Explain the key mechanisms driving atrial fibrillation, including electrical triggers, structural remodeling.
• Apply the latest ACC/AHA/HRS guideline updates to the management of atrial fibrillation.

Israel Henriquez, DO, Cardiology, Cardiovascular Institute of Palm Beach

Tiffany Di Pietro, DO, FACOI (she/her/hers), Founder/CEO, Di Pietro Health

Learning Objectives:

• Discover how to recharge your mindset and refocus your energy.
• Explore what the latest research says about thriving in work and life.
• Apply practical coaching tools to keep your team engaged, grounded, and growing.

Simon T. Bailey, MBA (he/him/his), Keynote Speaker and Author, Award-Winning Resilience Speaker

Learning Objectives:

• Understand evidence-based approaches to identifying eligible patients fort lung cancer screening and identifying high risk nodules
• Recognize the key barriers that contribute to low screening rates and describe the roles of primary care and pulmonary teams in implementing and sustaining a successful lung cancer screening program
• Apply collaborative strategies to improve referral workflows, patient education, and follow-up care based on real-world models and outcomes of multidisciplinary approaches to increase lung cancer screening.

Fatima Ali, DO, Interventional Pulmonologist, St. Luke's University Health Network

More details coming soon

Janice A. Knebl, DO, DO, FACP, MACOI, CPPS, DSWOP Endowed Chair & UNT Regents Professor, UNT Health and CMO UNT Health

Dominic F. Glorioso, Jr., DO, PhD, FACOI, FAAHPM, HMD (he/him/his), Associate Medical Director, Assistant Clinical Professor of Internal Medicine, Amedisys Hospice, Duquesne University College of Osteopathic Medicine

This session will provide an overview of measles epidemiology within the United States, with a focus on recent trends and implications for clinical practice. Attendees will gain key clinical pearls for identifying and managing measles, along with essential infection prevention strategies. The session will also address considerations around immunity, including vaccination and post-exposure guidance.

Learning Objectives:

• Describe the current epidemiology and trends of measles cases in the United States.
• Identify key clinical features and infection control measures essential for managing measles in healthcare settings.
• Explain immunity-related considerations, including vaccination recommendations and post-exposure protocols.

Mindy Sampson, DO, Clinical Assistant Professor of Medicine, Stanford University

MarkAlain Déry, DO, MPH, FACOI (he/him/his), Chief Innovation Officer, Access Health Louisiana

Mia A. Taormina, DO, FACOI (she/her/hers), Chair, Department of Infectious Disease, Duly Health and Care

More details coming soon

Steven Dinsmore, DO, FACOI, Retired

Dominic F. Glorioso, Jr., DO, PhD, FACOI, FAAHPM, HMD (he/him/his), Associate Medical Director, Assistant Clinical Professor of Internal Medicine, Amedisys Hospice, Duquesne University College of Osteopathic Medicine

Learning Objectives:

• Understand and appreciate standards of practice in the selection of empiric antibiotics for various conditions.
• Comprehend the importance of antibiotic stewardship to minimize risk of emerging antimicrobial resistance.
• Reconsider choice, route, and duration of antimicrobials to assure narrow spectrum and limit excessive antibiotic use.

Mia A. Taormina, DO, FACOI (she/her/hers), Chair, Department of Infectious Disease, Duly Health and Care

Learning Objectives:

• Understand the ethical implications of LTOT.
• Appreciate the diagnosis of OUD.
• Be compliant with the legal aspects of LTOT.

Dominic F. Glorioso, Jr., DO, PhD, FACOI, FAAHPM, HMD (he/him/his), Associate Medical Director, Assistant Clinical Professor of Internal Medicine, Amedisys Hospice, Duquesne University College of Osteopathic Medicine

Learning Objectives:

• Describe the key factors contributing to the emergence and re-emergence of infectious diseases and how limited government funding impacts public health infrastructure for surveillance and outbreak response.
• Analyze the challenges and consequences of reduced funding on the development, accessibility, and deployment of diagnostic tools, vaccines, and therapeutics for emerging infectious diseases.
• Develop strategic approaches for optimizing clinical and public health practices, including interdisciplinary collaboration and resource allocation, to effectively manage emerging infections despite financial constraints.

MarkAlain Déry, DO, MPH, FACOI (he/him/his), Chief Innovation Officer, Access Health Louisiana

Learning Objectives:

• Upon completion of this session learners will be able identify delirium and its subtypes.
• Upon completion of this session learner will be able to identify risk factors for delirium.
• Upon completion will be able to complete appropriate work up for delirium and treat pharmacologic and non-pharmacologic.

Antonio Graham, DO, Hospitalist/Internal Medicine, Johns Hopkins University School of Medicine

Dominic F. Glorioso, Jr., DO, PhD, FACOI, FAAHPM, HMD (he/him/his), Associate Medical Director, Assistant Clinical Professor of Internal Medicine, Amedisys Hospice, Duquesne University College of Osteopathic Medicine